Approval · Notice of Compliance 33466 · 2024
IBUPROFEN CAPLETS: Notice of Compliance 33466
Issued June 18, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33466
- Date
- June 18, 2024
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of private retailer label
- Canadian reference product
- ADVIL CAPLETS (Glaxosmithkline Consumer Healthcare Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | 02368080 | Marketed |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB